West Pharmaceutical Services Inc (WST)
Net profit margin
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 492,700 | 499,600 | 524,900 | 568,700 | 593,400 | 559,400 | 518,700 | 552,100 | 585,900 | 630,600 | 685,600 | 684,400 | 661,800 | 612,500 | 519,200 | 423,100 | 346,200 | 311,700 | 285,700 | 260,600 |
| Revenue (ttm) | US$ in thousands | 2,893,100 | 2,876,300 | 2,876,800 | 2,928,600 | 2,949,800 | 2,926,500 | 2,866,000 | 2,883,500 | 2,886,900 | 2,909,000 | 2,928,600 | 2,880,900 | 2,831,600 | 2,681,000 | 2,522,500 | 2,326,100 | 2,146,900 | 2,037,300 | 1,945,400 | 1,887,900 |
| Net profit margin | 17.03% | 17.37% | 18.25% | 19.42% | 20.12% | 19.11% | 18.10% | 19.15% | 20.30% | 21.68% | 23.41% | 23.76% | 23.37% | 22.85% | 20.58% | 18.19% | 16.13% | 15.30% | 14.69% | 13.80% |
December 31, 2024 calculation
Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $492,700K ÷ $2,893,100K
= 17.03%
The net profit margin of West Pharmaceutical Services Inc has shown a generally increasing trend from March 31, 2020 to December 31, 2021, indicating improved profitability over time. The margin started at 13.80% in March 2020 and steadily rose to 23.37% by December 2021. This upward trajectory reflects the company's ability to generate more profits relative to its revenue during this period.
However, starting from March 31, 2022, the net profit margin began to decline, dropping to 17.03% by December 31, 2024. This downward trend suggests some challenges in sustaining the high level of profitability seen in the previous years. It indicates that the company may have experienced increased costs or other factors impacting its bottom line performance.
Overall, while West Pharmaceutical Services Inc's net profit margin experienced significant growth in the earlier years, it started to decline in the later years of the data period. This changing trend in profitability warrants further investigation to understand the factors driving these fluctuations and to assess the company's overall financial health and performance.
Peer comparison
Dec 31, 2024